Researchers from Munich and Naples have shown that minimal modification of a synthetic peptide with anti-HIV activity results in a new compound with more than two orders of magnitude higher binding affinity to the chemokine ...
Aug 9, 2012
0
0
Thirty years ago today, on March 2, 1985, the Food and Drug Administration approved a new HIV test. It was the result of nine months of round-the-clock labor by dozens of scientists. Immediately adopted by the American Red ...
Mar 2, 2015
0
71
An international team led by Professor Jerome Estaquier from Universite Laval's Faculty of Medicine and the CHU de Quebec-Universite Laval Research Center may have discovered where in the body HIV takes refuge during antiretroviral ...
Dec 2, 2019
0
1
Drugs developed to treat AIDS and HIV could offer hope to patients diagnosed with the most common form of primary brain tumor.
Dec 15, 2021
0
98
Researchers report that they have determined the precise chemical structure of the HIV capsid, a protein shell that protects the virus's genetic material and is a key to its virulence. The capsid has become an attractive ...
May 29, 2013
0
0
As the world marks the 30-year anniversary of the first reporting of HIV/AIDS, now comes the realization of a new challenge for people with the incurable disease. For reasons not yet clear, people with HIV face a higher ...
Jun 6, 2011
0
0
(HealthDay)—A common drug used to treat nail fungus may hold promise against HIV, the virus that causes AIDS, according to a new study.
Sep 24, 2013
1
0
If HIV-infected adults in San Francisco began taking antiretroviral treatments as soon as they were diagnosed, the rate of new HIV infections among men who have sex with men would be cut by almost 6o percent over five years, ...
Apr 13, 2011
1
0
Researchers from the University of Liverpool and Queen's University Belfast have been awarded over £1m by the Engineering and Physical Sciences Research Council (ESPRC) to examine the use of nano-engineered microarray patches ...
Aug 20, 2019
0
4
A team of scientists led by the Institute of Biomaterials and Bioengineering at Tokyo Medical and Dental University (TMDU) have created novel molecules that prevent human immunodeficiency virus (HIV) particles from attacking ...
Apr 15, 2021
0
4
